Finerenone: A Pillar for the Treatment of Diabetic Kidney Disease
Editorial Finerenone: A Pillar for the Treatment of Diabetic Kidney Disease Bharat Nathoo Division of Nephrology, Mackenzie Health, Richmond Hill, L6C1R4, Ontario, Canada; [email protected] Received: 26 January 2025; Accepted: 28 January 2025; Published: 1 March 2025 Abstract: Diabetic kidney disease[DKD] has the potential to progress to end stage kidney disease as well as increase the risk of cardiovascular disease.. Remarkable advances have occurred in management of DKD., This review highlights the role of finerenone a novel nonsteroidal minerallocorticoid receptor antagonist in DKD.
Authors
- Bharat Nathoo
Publication Details
- Journal
- International Journal of Clinical and Translational Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.53941/ijctm.2025.100002
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00